Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Immuno-Response to Primary Cryotherapy for the Treatment of Prostate Cancer

NCT02250014 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT02250014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02250014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Immuno-Response to Primary Cryotherapy for the Treatment of Prostate Cancer
Lead sponsor
University of Colorado, Denver
Phase
Phase 1
Overall status
Completed
Start date
October 5, 2015
Completion date
December 21, 2020
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent prostate cancer, stage i prostate cancer, stage iia prostate cancer, stage iib prostate cancer